Cargando...

Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test

The Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV combination test received emergency use authorization approval by the United States Food and Drug Administration in December 2020, and Health Canada approval in January 2021. The performance characteristics of the GeneXpert Xpert Xpress SARS-CoV-2/Flu/RSV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Journal of Clinical Virology Plus
Autores principales: Johnson, Grant, Zubrzycki, Arek, Henry, Michele, Ranadheera, Charlene, Corbett, Cindi, Meyers, Adrienne F.A., Sandstrom, Paul A., Becker, Michael G.
Formato: Artigo
Lenguaje:Inglês
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8040320/
https://ncbi.nlm.nih.gov/pubmed/35262002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcvp.2021.100014
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!